Syncona 3Q Net Asset Value Rose; Portfolio Companies Continued to Attract Capital
10 Fevereiro 2022 - 06:26AM
Dow Jones News
By Anthony O. Goriainoff
Syncona Ltd. said on Thursday that its net asset value rose 16%
in the third quarter compared with the previous quarter, and that
its portfolio companies continued to attract substantial capital in
the period.
The London-listed life-sciences investment company said net
assets at Dec. 31 were 1.34 billion pounds ($1.81 billion) compared
with GBP1.15 billion on Sept. 30.
The company said it received five significant financing
commitments in the period ended Dec. 31 totaling $674 million of
capital across Autolus, Quell, Anaveon, Gyroscope and Clade.
The company said it expects the forthcoming sale of portfolio
company Gyroscope Therapeutics to Novartis AG to deliver a GBP221
million uplift to net asset value. The company said it anticipates
upfront proceeds on closing to be GBP326.7 million.
Syncona said in December that Novartis had agreed to acquire
Gyroscope for up to $1.5 billion.
"Many of our companies are approaching clinical data readouts in
the next 12 months, and we remain confident in the potential of our
portfolio to drive value and deliver transformational treatments to
patients," Chief Executive Martin Murphy said.
Shares at 0845 GMT were up 6.80 pence, or 3.5%, at 202
pence.
Write to Anthony O. Goriainoff at
anthony.orunagoriainoff@dowjones.com
(END) Dow Jones Newswires
February 10, 2022 04:11 ET (09:11 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Novartis (NYSE:NVS)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024